↓ Skip to main content

Cochrane Database of Systematic Reviews

Home versus hospital intravenous antibiotic therapy for cystic fibrosis

Overview of attention for article published in this source, March 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

blogs
1 blog
twitter
5 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
85 Mendeley
Title
Home versus hospital intravenous antibiotic therapy for cystic fibrosis
Published by
John Wiley & Sons, Ltd, March 2012
DOI 10.1002/14651858.cd001917.pub3
Pubmed ID
Authors

Balaguer, Albert, González de Dios, Javier

Abstract

Recurrent endobronchial infection in cystic fibrosis requires treatment with intravenous antibiotics for several weeks usually in hospital, affecting health costs and quality of life for patients and their families.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 85 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Iran, Islamic Republic of 1 1%
Australia 1 1%
Unknown 81 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 15 18%
Student > Ph. D. Student 13 15%
Researcher 12 14%
Student > Bachelor 11 13%
Other 5 6%
Other 14 16%
Unknown 15 18%
Readers by discipline Count As %
Medicine and Dentistry 29 34%
Nursing and Health Professions 11 13%
Psychology 8 9%
Social Sciences 3 4%
Business, Management and Accounting 2 2%
Other 14 16%
Unknown 18 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 July 2013.
All research outputs
#413,336
of 6,508,999 outputs
Outputs from this source
#1,901
of 8,048 outputs
Outputs of similar age
#5,097
of 83,459 outputs
Outputs of similar age from this source
#21
of 123 outputs
Altmetric has tracked 6,508,999 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,048 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.8. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 83,459 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 123 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.